{"transactions":[{"id":1708767,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2023-12-16T02:46:25.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024."}],"balance_after":1000000,"derivative":{"exercise_price":0.247,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-23-045171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223045171/ownership.xml","form_type":"4"}},{"id":2077376,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2022-12-22T16:22:03.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023."}],"balance_after":625000,"derivative":{"exercise_price":0.53,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001493152-22-036238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315222036238/ownership.xml","form_type":"4"}},{"id":2471216,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2021-12-16T02:25:54.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022."}],"balance_after":500000,"derivative":{"exercise_price":0.92,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000905718-21-001613","document":"matinas_fm4dec142021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571821001613/matinas_fm4dec142021.xml","form_type":"4"}},{"id":2924947,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-04T23:30:10.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022."}],"balance_after":500000,"derivative":{"exercise_price":1.36,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-21-000132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315221000132/ownership.xml","form_type":"4"}},{"id":3103916,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-06-19T21:30:14.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT\ndata (the \"Milestone\"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such\nMilestone."}],"balance_after":175000,"derivative":{"exercise_price":0.815,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001493152-20-011533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220011533/ownership.xml","form_type":"4"}},{"id":3321643,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T21:05:59.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021."}],"balance_after":350000,"derivative":{"exercise_price":2.27,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-20-000124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220000124/ownership.xml","form_type":"4"}},{"id":3358447,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-11-26T15:00:11.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":58000,"price":1.2269,"value":71160.2,"ownership":{"direct":true},"balance_after":94500,"source":{"system":"sec-edgar","filing":"0001493152-19-018412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315219018412/ownership.xml","form_type":"4"}},{"id":3358446,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-11-26T15:00:11.000Z","date":"2019-11-22","kind":"purchase","acquired":true,"shares":36500,"price":1.2002,"value":43807.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $1.17 to $1.23, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":36500,"source":{"system":"sec-edgar","filing":"0001493152-19-018412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315219018412/ownership.xml","form_type":"4"}},{"id":3659799,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-02-13T23:42:36.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 25% of the shares on February 11, 2020 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on March 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":275000,"derivative":{"exercise_price":1.08,"expiration_date":"2029-02-10","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000905718-19-000114","document":"matinasbiofm4_feb112019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571819000114/matinasbiofm4_feb112019.xml","form_type":"4"}},{"id":3703114,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96124,"kind":"person","name":"Kucinski Keith A","position":1,"cik":"0001763405","reported_name":"Kucinski Keith A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-01-04T21:12:29.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 62,500 shares on January 2, 2020 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":250000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000905718-19-000023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571819000023/ownership.xml","form_type":"4"}}]}